Innovation, Acceleration and Transformation: How the Pandemic is Changing the Medtech Industry
Tuesday, September 21, 2021 | 1:15 PM – 2:00 PM ET | Virtual
Moderator:
Jonas Funk
Managing Director
L.E.K. Consulting
Speakers:
Nacho Abia, COO, Olympus Corporation and
CEO, Olympus Corporation of Americas
Nina Goodheart, Sr VP and President, Structural Heart & Aortic
Medtronic
Bill Hawkins, III, Senior Advisor, EW Healthcare Partners
Kevin Lobo, Chair and Chief Executive Officer, Stryker
Tom Polen, Chairman, Chief Executive Officer and President, BD
The novel coronavirus has had an impact on everything from clinical trials to health care delivery. In this session, medtech leaders will share what the pandemic has revealed about the industry’s strengths and vulnerabilities, along with the changes they’ve made post-COVID-19. We’ll also look around the corner at how the changing landscape will affect the way medtech companies operate.